Results 151 to 160 of about 7,263 (276)

Effects of palonosetron on prolongation of corrected QT intervals may be less than reliable [PDF]

, 2014
Jeounghyuk Lee, Junyong In
openalex   +1 more source

Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy

, 2015
Luigi Celio, Monica Niger, Francesca Ricchini, Francesco Agustoni   +3 more
openalex   +2 more sources

One-Day Versus Three-Day Dexamethasone in Combination with Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Individual Patient Data-Based Meta-Analysis [PDF]

, 2019
Yuki Okada, Koji Oba, Naoto Furukawa, Yoshimasa Kosaka, Kenji Okita, Satoshi Yuki, Yoshito Komatsu, Luigi Celio, Matti Aapro   +8 more
openalex   +1 more source

Intravenous palonosetron and pethidine as prophylaxis of post spinal shivering: A comparative study

, 2022
Chandan Kumar Banik, Prosanjit Mazumder, Gopa Kundu, Shamim Ara Begum   +3 more
openalex   +2 more sources

Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)

Drug Design, Development and Therapy, 2014
Rudolph M Navari Cancer Care Program, Eastern Europe, World Health Organization, Mishawaka, IN, USA; Indiana University School of Medicine, South Bend, IN, USA; South Bend Medical Services Corporation, IN, USA Abstract: Chemotherapy-induced ...
Navari RM
doaj  

Management of postoperative nausea and vomiting: focus on palonosetron

, 2008
Michael Paech, Muchatuta
openalex   +2 more sources

Efficacy and Safety of Intravenous Palonosetron against Ondansetron in Preventing Postoperative Nausea Vomiting in Patients Undergoing General Anaesthesia: Double blind Randomized Control Study in Tertiary Care Hospital, Tamil Nadu, India

, 2022
Sunil Mhatarba Vishwasrao, Sufala Sunil Vishwasrao, Amar Nagesh Kumar   +2 more
openalex   +1 more source

Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-induced Nausea and Vomiting in Children with Cancer [PDF]

, 2016
Basch, Bauters, Bodge, Chanthawong, Choi, Choo, Dupuis, Dupuis, Dupuis, Dupuis, Flank, Flank, Gardani, Gore, Guyatt, Guyatt, Hachimi-Idrissi, Hesketh, Higi, Kaiser, Kang, Massa, McCabe, Musso, Navari, Sanofi-Aventis Canada Inc, Schnell, Shillingburg, Shiu, Smith, Smith, Wit   +31 more
core   +1 more source

Informe técnico palonosetron inyectable

, 2013
Revisada la evidencia observamos una ventaja de hasta 19% en disminución en emesis aguda en regímenes altamente emetogénicos. Respecto a la seguridad es similar a la terapia estándar aunque reportes muestran una cierta ventaja respecto a la prolongación del intervalo QT, sin embargo las múltiples interacciones medicamentosas por el CYP3A4 y CYP2C9 ...
openaire   +2 more sources

PCN5 EFFICACY OF PALONOSETRON (PAL) COMPARED TO OTHER SEROTONIN INHIBITORS (5-HT3R) IN PREVENTING CHEMOTHERAPYINDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING MODERATELY OR HIGHLY EMETOGENIC (MOHE) TREATMENT: AN UPDATE OF THE PREVIOUSLY PUBLISHED SYSTEMATIC REVIEW AND META-ANALYSIS

, 2010
T.E.A. Botrel, O Clark, LGO Clark, Ludovica Paladini, E Faleiros, B Pegoretti   +5 more
openalex   +1 more source